A

AptaBio Therapeutics Inc
KOSDAQ:293780

Watchlist Manager
AptaBio Therapeutics Inc
KOSDAQ:293780
Watchlist
Price: 8 980 KRW 0.56% Market Closed
Market Cap: ₩241.4B

Net Margin

-587.9%
Current
Improving
by 7 899.4%
vs 3-y average of -8 487.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-587.9%
=
Net Income
₩-20.2B
/
Revenue
₩3.4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-587.9%
=
Net Income
₩-20.2B
/
Revenue
₩3.4B

Peer Comparison

Country Company Market Cap Net
Margin
KR
AptaBio Therapeutics Inc
KOSDAQ:293780
241.4B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
394.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...

Market Distribution

Lower than 98% of companies in Korea
Percentile
2st
Based on 2 632 companies
2st percentile
-587.9%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

AptaBio Therapeutics Inc
Glance View

Market Cap
241.4B KRW
Industry
Biotechnology

Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.

Intrinsic Value
1 904.1 KRW
Overvaluation 79%
Intrinsic Value
Price
A
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-587.9%
=
Net Income
₩-20.2B
/
Revenue
₩3.4B
What is AptaBio Therapeutics Inc's current Net Margin?

The current Net Margin for AptaBio Therapeutics Inc is -587.9%, which is above its 3-year median of -8 487.3%.

How has Net Margin changed over time?

Over the last 3 years, AptaBio Therapeutics Inc’s Net Margin has increased from -24 420.4% to -587.9%. During this period, it reached a low of -24 651.1% on Sep 30, 2023 and a high of -587.9% on Oct 30, 2025.

Back to Top